Elon Musk 'Microdoses' On Ketamine For Depression: WSJ

Comments
Loading...

In a trend that’s raising eyebrows and questions about corporate responsibility, Silicon Valley executives, including Elon Musk and Sergey Brin, are increasingly turning to psychedelics such as ketamine, LSD, and magic mushrooms for business insights and personal growth, The Wall Street Journal reports.

Psychedelics in the Boardroom

These substances, once relegated to after-hours experimentation, have permeated corporate culture, with proponents arguing they can lead to business breakthroughs. This shift has left company leaders grappling with the implications of a workforce that frequently uses drugs, most of which are illegal.

Microdosing for Mindfulness

Many tech workers are microdosing psychedelics, a practice that involves taking small amounts of these substances to enhance creativity, focus, and mental clarity. “There are millions of people microdosing psychedelics right now,” said Karl Goldfield, a former sales and marketing consultant who advises colleagues on microdosing.

Musk’s Ketamine Use

Elon Musk, the founder of Tesla and SpaceX, reportedly uses ketamine, both in microdoses for depression and in larger doses at parties. This information comes from individuals who have witnessed his drug use and others with direct knowledge of it, according to WSJ.

Benzinga Newsbot

Hi, I am the Benzinga Newsbot! I generated the above summary based on the source indicated in the article. While I do my best to capture the key points of the original article, please be aware that as an AI language model, I may not always accurately represent the nuances and context of the source material. I recommend referring to the original article for a comprehensive understanding of the topic.

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.